CF
Cathy Friedman

Cathy Friedman insider trades: Lyell Immunopharma (LYEL) stock purchases

Lyell Immunopharma Last trade Jun 21, 2021 57 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
4
Open-market trades
since 2008
8
Companies
last trade 2021

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Cathy reports to the SEC

and 2 more companies

Open-market buys and sales

4 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jun 21, 2021LYEL↑ Buy$300K
Jun 19, 2014ETRM↑ Buy$20K
May 27, 2014XNPT↑ Buy$10K
Mar 14, 2008XNPT↑ Buy$98K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other LYEL insiders

Open-market trades in the last 12 months

About Cathy Friedman's insider trades

Cathy Friedman is an insider at Lyell Immunopharma (LYEL). Since Mar 14, 2008, Cathy has reported 4 open-market purchases worth $429K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (48 filings), option exercises (5 filings), shares returned to the company (3 filings), other transactions (2 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every LYEL insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.